ADAM10 and Alzheimer disease: Under AD conditions, increased ectodomain shedding of TREM2 by the ADAM metallopeptidase domain 10/17 (ADAM10/17) proteases generates soluble TREM2 (sTREM2), which is detectable in cerebrospinal fluid (CSF).